Contextual Medicine SIG Information

Printer-friendly version

Contextual Medicine Special Interest Group

Affiliated 2012

Contact Information

Ellen Lewis, MD
Psychiatrist
Denver, CO, USA

2012-2014 Officers

Ellen Lewis – President
Rob Purssey - Vice–President
Maarten Aalberse – Member at Large
Laura Blakley – Member at Large
Maria Karekla – Member at Large 

Staci Martin - Programs Chair

Sarah Staats - Student Representative

Mission Statement

The mission of the Contextual Medicine SIG is to provide a forum to discuss all aspects of medicine, approached from contextual behavioral science.

Topics of Interest

--Human physiology, neuroscience, medicine, and their relations within the broader field of evolutionary science.
--Developing CBS-based case conceptualization for psychological flexibility and psychopathology, integrated with models and language familiar to medical practitioners.
--Functional contextual study of the effect of drugs on human behavior, expanding the Behavioral Pharmacology tradition with conceptual, research, and clinical applications.
--Public health, socio-cultural, and economic issues relevant to practices of medicine including prescribing practices, and local variation in such issues. 
 

Description of SIG membership 

The membership is open to all ACBS members, of all categories, interested in these issues from the perspective of contextual behavioral science. Please note that all members are welcome to join; this SIG is not limited to people in prescribing roles.

SIG Activities

1. Annual meeting at the World Conference.
2. Maintain the Contextual Medicine listserve.
3. Consider collaboration with other ACBS SIGs, such as the Research and Clinical Practice Collaborative SIG, to further develop research and clinical directions from this conceptual basis.
4. Write a request to the Institute of Medicine calling for study of certain specific current pharmacology practices, in light of recent findings of long-term harm. We will discuss which specifics, of which medications, to include in this, and how best to communicate the request. We will consider including research findings from ACT and RFT-based outcome studies. We will consider including recommendations for best pharmacological practices, evidence-based non-pharmaceutical approaches, and recommendations to use a functional contextual approach to guide future research. We will consider collaborating with other organizations to strengthen this request.
5. Other activities to be determined.